AKT1 and ovarian carcinoma: The expression profile of the ligands and receptor genes of the PI3K-AKT signaling pathway in the CAFs-cancer cell crosstalk revealed genes previously associated with the outcome, response to treatment, or overall survival in ovarian cancer (Fig. 6d).